Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
08/2010
08/31/2010US7785568 Sterically stabilized liposomes with hydrophilic polymers on surface; computed tomography
08/31/2010US7785566 useful in the treatment of heart failure, cardiac arrhythmias and other diseases where fibrosis is prominent such as in COPD, liver fibrosis, and atherosclerosis comprising a targeting moiety that demonstrates a higher binding affinity to the AT1 receptor than the native octapeptide Ang II
08/31/2010US7785565 chelate compounds such as N-[(R)-2-Amino-3-(p-5-[(2,5-dioxopyrrolidin-1-yl)oxy]-5-oxo-N-pbenylpentanamide)propyl]-trans-(S,S)-cyclohexane-1,2-diamine-N,N,N',N'',N''-penta-t-butylacetate, used for peptides, proteins, dendrimers or radionuclides, used in diagnosis, imaging and treatment of diseases
08/31/2010US7785564 Design and synthesis of renal dipeptidase inhibitors
08/26/2010WO2010096486A1 Methods and kits for diagnosis of cancer and prediction of therapeutic value
08/26/2010WO2010095461A1 Novel monoclonal antibody, and use thereof
08/26/2010WO2010094068A1 Treatment of chronic inflammatory conditions
08/26/2010WO2010059905A3 Imaging ligands for the dopamine d2 receptor
08/26/2010WO2010011964A3 Imaging agents useful for identifying ad pathology
08/26/2010US20100215579 Phen-naphthalene and phen-quinoline derivatives and their use for binding and imaging amyloid plaques
08/26/2010US20100215578 Catalytic Radiofluorination
08/26/2010US20100215577 Compositions and methods for visualizing and eliminating cancer stem cells
08/26/2010US20100215576 Diagnosis and treatment of neuroectodermal tumors
08/26/2010US20100215575 Systemic Administration of Chlorotoxin Agents for the Diagnosis and Treatment of Tumors
08/26/2010US20100215574 Process for producing an injectable medicament preparation
08/26/2010US20100215573 Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders
08/26/2010US20100215572 Methods of treatment using ldcam
08/26/2010US20100215571 Polymer based radionuclide containing particulate material
08/26/2010DE102009007799A1 Molekül zur Funktionalisierung eines Trägers, Bindung eines Radionuklids an den Träger und Radionuklidgenerator zur Herstellung des Radionuklids sowie Herstellungsverfahren Molecule for the functionalization of a carrier, binding of a radionuclide to the carrier, and radionuclide generator for the production of the radionuclide and the production method
08/26/2010CA2789515A1 Treatment of chronic inflammatory conditions
08/26/2010CA2752510A1 Methods and kits for diagnosis of cancer and prediction of therapeutic value
08/25/2010EP2221316A1 Anti-CD19 antibody therapy for autoimmune disease
08/25/2010EP2219683A2 Targeted radiotherapy
08/25/2010EP2219682A1 Methods for imaging dopamine transporter level
08/25/2010EP2219681A2 Imaging method
08/25/2010EP1228208B1 36p6d5: secreted tumor antigen
08/25/2010CN101812134A Antibodies that bind cell-associated ca 125/0722p and methods of use thereof
08/25/2010CN101810858A Microcrystalline glass microspheres with magnetism and radioactivity, preparation method and application thereof
08/25/2010CA2694683A1 Pharmaceutical compounds
08/25/2010CA2694679A1 Pharmaceutical compositions
08/25/2010CA2694672A1 Pharmaceutical compounds
08/24/2010US7781566 Peptides, mimetics and antibodies of erbB, TNF, and IgSF receptors; for preventing, treating, and diagnosing mammalian cancer tumors
08/24/2010US7781476 Serotonin and melatonergic ligands such as 10-(4-Methylpiperazin-1-ylmethyl)-5-thia-4b-aza-indeno[2,1-a]indene-5,5-dioxide, used for the treatment of psychological disorders, side effect reduction of antipsychotic drugs, neurodegenerative disorders, chemotherapy-induced vomiting and eating disorders
08/24/2010US7780948 implanting post-procedure cavity implant into cavity through incision and through access path, and closing incision, wherein implanted post-procedure cavity implant swells within biological fluid environment of cavity to a post-implantation state and no longer fits through the access path
08/24/2010US7780947 chelate compounds such as 2-[[2,2-bis[[bis(carboxymethyl)amino]methyl]-3-[(4-nitrophenyl)methoxy]propyl]-(carboxymethyl)amino]acetic acid, useful for complexing with metal ions, including radioisotopes, for use in medical diagnosis such as magnetic resonance imaging
08/24/2010CA2329320C Chlorin and bacteriochlorin-based aminophenyl dtpa and n2s2 conjugates for mr contrast media and radiopharmaceuticals
08/19/2010WO2010092114A1 Use of buffers for radionuclide complexation
08/19/2010WO2010092111A2 Compounds for non-invasive measurement of aggregates of amyloid peptides
08/19/2010WO2010073126A3 Compounds useful in delivering anti-neoplastic therapy and diagnostic imaging to hypoxic cells and methods of use thereof
08/19/2010WO2010072342A3 A method for synthesis of a radionuclide-labeled compound using an exchange resin
08/19/2010WO2009140210A3 Radiotracers for imaging cannabinoid sub-type1 (cb1) receptor
08/19/2010US20100209507 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
08/19/2010US20100209345 Fluorinated Ligands for Targeting Peripheral Benzodiazepine Receptors
08/19/2010US20100209344 Radio-methyl Vorozole and Methods for Making and Using the Same
08/19/2010US20100209343 Methods and kits for diagnosis of cancer and prediction of therapeutic value
08/19/2010US20100209342 Apcdd1 inhibitors for treating, diagnosing or detecting cancer
08/19/2010US20100209341 Treatment of chronic inflammatory conditions
08/19/2010US20100209340 Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of p13k-alpha for the treatment of cancer
08/19/2010CA2752181A1 Use of buffers for radionuclide complexation
08/18/2010EP2218464A1 Compounds for non-invasive measurement of aggregates of amyloid peptides
08/18/2010EP2218463A1 Use of novel compound having affinity for amyloid, and process for production of the same
08/18/2010EP2217599A1 Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes
08/18/2010EP1631561B1 Compositions and methods for non-invasive imaging of soluble beta-amyloid
08/18/2010EP1499584B1 Tumor imaging compounds
08/18/2010EP1461360B1 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
08/18/2010EP1417222B1 Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralizing anti-p17 antibodies which specifically recognize said neutralizing epitope
08/18/2010CN101805247A Fluorine marking cyclofenil derivative as well as reference compound, midbody, preparation method and application thereof
08/18/2010CN101338303B Adenovirus marked by radionuclide
08/17/2010US7776361 NELL-1 enhanced bone mineralization
08/17/2010US7776332 infant formula which includes casein protein and whey protein; malnutrition; free of arginine and histidine; has an amino acid profile which is close to that of human milk
08/17/2010US7776330 Carcinoembryonic antigen (CEA); utilizes crystallographic structural data to select immunoglobulin framework having maximum structural overlap non-human donor molecule
08/17/2010US7776311 D-amino acid peptides
08/17/2010US7776310 non-polymeric biodegradable implantable seeds
08/17/2010US7776309 Such as fluoromethyl-tyrosine and/or N,N-methyl-N-fluoromethylethanolamine
08/17/2010CA2450637C Solid-phase nucleophilic fluorination
08/17/2010CA2412854C Vitronectin receptor antagonist pharmaceuticals for use in combination therapy
08/17/2010CA2284665C Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors
08/17/2010CA2224153C Radiolabeled peptide compositions for site-specific targeting
08/12/2010US20100204782 Radiopaque implantable collagenous biomaterial device
08/12/2010US20100202965 Annulus fibrosus detection in intervertebral discs using molecular imaging agents
08/12/2010US20100202964 Organ Homing Genes of Cancer Metastases
08/12/2010US20100202963 Therapies for hematologic malignancies
08/12/2010US20100202962 Cripto blocking antibodies and uses thereof
08/12/2010US20100202961 Immunological reagents for therapeutic use, in radioimmunotherapy (RAIT), and diagnostic use, in radioimmunodetection (RAID) and magnetic resonance imaging; conjugated drug as antiinflammatory, or anticarcinogenic agents; drug targets; tissue-targeted therapy
08/11/2010EP2216342A1 Anti-CD19 antibodies
08/11/2010EP2216052A1 Use of novel compound having affinity for amyloid, and process for production of the same
08/11/2010EP2216051A1 Use of novel compound having affinity for amyloid, and process for production of the same
08/11/2010EP2216050A1 Utilization of novel compounds with amyloid affinity and method of producing the same
08/11/2010EP2214722A1 Stabilization of radiopharmaceuticals
08/11/2010EP2214721A2 Fluorinated dihydrotetrabenazine ether imaging agents and probes
08/11/2010EP2214720A2 Purification of 68ge/68ga generator eluate from fe(iii) intended to improve specific radioactivity of 68ga-based radiopharmaceuticals
08/11/2010CN101801421A Compositions emitting positrons and containing inorganic particles, and use thereof in medicine, especially for diagnostic processes
08/11/2010CN101797393A Malignant lymphoma radioactive target molecule imaging agent and/or target therapeutic agent
08/11/2010CN101797392A Palladium-103 and io-125 compound sealed seed source, source core and source core preparation method
08/10/2010US7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
08/10/2010US7772222 Reaction product of stimulant and ligand; central nervous system disorders
08/10/2010US7771704 Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof
08/10/2010CA2426584C Radiopharmaceutical formulations
08/05/2010WO2010087612A1 Complex of bifunctional chelating agent and mannosyl human serum albumin
08/05/2010WO2010086398A1 Radioiodination method
08/05/2010WO2010063701A3 In vivo imaging method for parkinson' s disease
08/05/2010US20100199362 Wnt ligands involved in blood-brain barrier development and uses therefor
08/05/2010US20100196989 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof
08/05/2010US20100196274 Methods for Diagnosing Diseases and Evaluating Treatments Therefor Using Pet
08/05/2010US20100196273 Novel agent for in vivo pet imaging of tumor proliferation
08/05/2010US20100196272 Compositions for radiolabeling diethylenetriaminepentaacetic acid (dtpa)-dextran
08/05/2010US20100196271 Cage-Like Bifunctional Chelators, Copper-64 Radiopharmaceuticals and PET Imaging Using the Same
08/05/2010US20100196270 Radiofluorination methods
08/05/2010US20100196269 Spirocyclic heterocyclic derivatives and methods of their use
08/05/2010US20100196268 Compositions and methods for treatment of tumors by direct administration of a radioisotope
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 243